SEC Form 4 · accession 0001225208-16-033173

PFIZER INC · PFE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Group President

Period of report

May 10, 2016

Accepted (ET)

May 11, 2016 · 6:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000078003

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	May 10, 2016	M	41,700	$25.87	A	200,399	D
Common Stock	May 10, 2016	S	400	$33.54	D	199,999	D
Common Stock	May 10, 2016	S	500	$33.57	D	199,499	D
Common Stock	May 10, 2016	S	700	$33.55	D	198,799	D
Common Stock	May 10, 2016	S	782	$33.50	D	198,017	D
Common Stock	May 10, 2016	S	1,400	$33.56	D	196,617	D
Common Stock	May 10, 2016	S	1,475	$33.49	D	195,142	D
Common Stock	May 10, 2016	S	4,525	$33.58	D	190,617	D
Common Stock	May 10, 2016	S	14,800	$33.52	D	175,817	D
Common Stock	May 10, 2016	S	17,118	$33.53	D	158,699	D
Common Stock	holding	—	—		—	1,306	I	By Rule 16b-3 Plan
Common Stock	holding	—	—		—	1,348	I	By Trustee under the Pfizer Share Ownership Plan

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$25.87	May 10, 2016	M	41,700	D	—	Feb 21, 2017	Common Stock	41,700	0	D